I-Tirzepatide Hloyini Ukuhlanzeka Okuphezulu okuphezulu 99% Peptide Powder Tr 10mg 15mg 20mg 20mg 20mg 30

I-TirzePatide i-anucose-ancike i-insulinotropic-ancike e-anulitotropic-e-PelpEptide / glucagon-efana ne-peptide 1 (glp-1) i-agonist e-United States njenge-advinct yokudla nokuzivocavoca ukuthuthukisa ukulawulwa kwe-glycemic kubantu abadala abanesifo sikashukela 2 nangaphansi kokusetshenziswa ku Ukuphathwa kwesisindo okungamahlalakhona, imicimbi emikhulu yenhliziyo yenhliziyo kanye nokuphathwa kwezinye izimo, kufaka phakathi ukwehluleka kwenhliziyo ngengxenye egciniwe ye-Ejection kanye nokukhuluphala kanye nokungeyona i-CIRRRHRIC Isigaba 3 sedlula uhlelo lokuqulwa kwecala lwe-1-5 lwenzelwe ukuhlola ukusebenza kahle kwe-tirzepatide okungu-5, 10, 10 no-15 mg), njengokwelashwa okubanzi noma okuhlanganisiwe kwesimo sabantu esinesifo sikashukela sohlobo 2. Ukusetshenziswa kweTirzePtide ezifundweni zemitholampilo kuhlotshaniswe nokuncishiswa okumakiwe kwe-hemoglobin (-1.87 kuya ku -2.59%, -6 kuya ku-28 mmol / Isisindo somzimba (-6.2 kuya ku -12.9 kg), kanye nokuncipha kwamapharamitha ngokuvamile Kuhlotshaniswa nobungozi obuphakeme be-Cardiometabolic njengengcindezi yegazi, i-visceral adipoty kanye nokujikeleza kwe-triglycerides. I-TirtzePatide ibibekezeleleke kahle, ngokuba nengozi ephansi ye-hypoglycaemia lapho isetshenziswa ngaphandle kwe-insulin noma i-insulin onokhokho futhi ikhombise iphrofayili yezokuphepha efanayo nekilasi le-purp-1 receptor agonist. Ngokuvumelana nalokhu, ubufakazi obuvela kulezi zivivinyo zomtholampilo bubonisa ukuthi i-tiirzepatide inikeza ithuba elisha lokunciphisa ngempumelelo kwe-hemoglobin esebenza ngempumelelo kanye nesisindo somzimba kubantu abadala abanesifo sikashukela sohlobo 2.